Correction: Survival and hospitalization among patients with acute myeloid leukemia treated with azacitidine or decitabine in a large managed care population: a real-world, retrospective, claims-based, comparative analysis

Míreanna Comhchosúla

• Survival and hospitalization among patients with acute myeloid leukemia treated with azacitidine or decitabine in a large managed care population: a real-world, retrospective, claims-based, comparative analysis
  le: Smith, B Douglas, et al.
  Foilsithe: (2014)
• Real-world experience of venetoclax with azacitidine for untreated patients with acute myeloid leukemia
  le: Winters, Amanda C., et al.
  Foilsithe: (2019)
• A comparison of azacitidine and decitabine activities in acute myeloid leukemia cell lines.
  le: Paul W Hollenbach, et al.
  Foilsithe: (2010-01-01)
• A Comparison of Azacitidine and Decitabine Activities in Acute Myeloid Leukemia Cell Lines
  le: Hollenbach, Paul W., et al.
  Foilsithe: (2010)
• Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia
  le: DiNardo, Courtney D., et al.
  Foilsithe: (2019)